comparemela.com

Latest Breaking News On - Eiger biopharmaceuticals daily - Page 1 : comparemela.com

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Head-To-Head Survey: Eiger BioPharmaceuticals (NASDAQ:EIGR) and XOMA (NASDAQ:XOMAP)

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) and XOMA (NASDAQ:XOMAP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Insider and Institutional Ownership 62.5% of Eiger BioPharmaceuticals shares […]

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

Investment analysts at StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Eiger BioPharmaceuticals has a 52-week low of $1.10 and a 52-week high of $43.35. The stock has […]

StockNews com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance The stock’s 50-day moving average is $5.04 and its 200 day moving average is $7.14. The firm has a market cap […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.